Associate Professor Peta-Ann Teague is a GP, A/Prof at the School of Medicine and Dentistry at James Cook University and Director of Generalist Medical Training.

We discuss cognitive bias, the importance in being aware of these so we can develop our professional selves, their role in clinical practice, the differing categories and how we can manage them.

This episode is only relevant really to RACGP registrars and their respective supervisors who are teaching them so sorry to everyone else! But it is a source of significant anxiety (and requests to me to do an episode on) so I have covered it.

I shall cover the RACGP criteria of an excellent candidate (public info), the common mistakes I see registrars make and break down each area in more detail i.e. history, examination, investigations, differentials and management, and finally some further resources

Good luck everyone, but remember - your training is about learning to be a great GP, not just passing exams!

This episode is only relevant really to RACGP registrars and their respective supervisors who are teaching them so sorry to everyone else!  But it is a source of significant anxiety (and requests to me to do an episode on) so I have covered it.

I shall cover the RACGP criteria of an excellent candidate (public info), the common mistakes I see registrars make and break down each area in more detail i.e. history, examination, investigations, differentials and management, and finally some further resources

Finally I am doing a specific child health topic after multiple attempts!

Today I am joined by Dr Anthony Morosini Paediatrician in both the public and private sector. He has an interest in evaluating growth so we had a nice discussion about some of the general principles, history, examination, investigations, management and variants of pathological and non-pathological growth patterns.

As always - enjoy!

Finally I am doing a specific child health topic after multiple attempts!

Today I am joined by Dr Anthony Morosini Paediatrician in both the public and private sector.  He has an interest in evaluating growth so we had a nice discussion about some of the general principles, history, examination, investigations, management and variants of pathological and non-pathological growth patterns.

As always - enjoy!

Today I am joined for an online chat by GP and medicolegal advisor for MDO Avant Dr Peter Walker. Areas we discuss include:

1. What are the most common reasons for doctors seeking medicolegal advice?
2. What are the common reasons patients and colleagues complain?
3. What is the "complaint" process and possible outcomes?
4. How can you reduce your medicolegal risk?

Today I am joined for an online chat by GP and medicolegal advisor for MDO Avant Dr Peter Walker.  Areas we discuss include:  

What are the most common reasons for doctors seeking medicolegal advice? 

What are the common reasons patients and colleagues complain?

What is the “complaint” process and possible outcomes? 

How can you reduce your medicolegal risk?

Just me today. Ironically I have to postpone an interview with a paediatrician due to my son being sick.

So instead I am covering some of the topics people have asked me about including acne management and because I love a bit of medical history, I am talking about the interesting history of anaesthesia. Finally I was stimulated by a recent RACGP AFP article to talk about the importance of assessing lifestyle history in detail to personalise and optimise lifestyle therapy.

References:

1. Kurt Gabauer, Acne in Adolescents, RACGP AFP, 2017
2. Emmy Graber, Treatment of Acne Vulgaris, UpToDate, 2017
3. Dover et al, Light-based, adjunctive and other therapies for acne vulgaris, UpToDate, 2017
4. Amanda Oakley, Acne management, Dermnet NZ, 2014
5. Titus et al, Diagnosis and Treatment of Acne, AAFP (USA), 2012
6. Lifestyle as Medicine RACGP AFP - https://www.racgp.org.au/afp/2016/april/lifestyle-as-medicine-%E2%80%93-past-precepts-for-present-problems/
7. Lifestyle risk factors and corresponding levels of clinical advice and counselling in GP https://www.racgp.org.au/afp/2017/october/lifestyle-risk-factors-and-corresponding-levels-of-clinical-advice/#13
8. Denney-Wilson E, Fanaian M, Wan Q, Vagholkar S, Schütze H, Harris M. Lifestyle risk factors in general practice – Routine assessment and management. Aust Fam Physician 2010

Just me today.  Ironically I have to postpone an interview with a paediatrician due to my son being sick.  

So instead I am covering some of the topics people have asked me about including acne management and because I love a bit of medical history, I am talking about the interesting history of anaesthesia. Finally I was stimulated by a recent RACGP AFP article to talk about the importance of assessing lifestyle history in detail to personalise and optimise lifestyle therapy.

Surrounded by the familiar beeps and glow of the hospital surgical theatres I had a thoroughly enjoyable chat with scrubs-donned Dr Johan Van Den Bogaerde Gastroenterologist and researcher. We discuss probiotics and the various relevant themes around them. Topics we discuss include: - What are probiotics and some important principles - How do they work? - Evidence for different conditions - IBD, IBS, diarrhoeal disorders, helicobacter pylori, atopic eczema and others - Research bias - Working with real people who are suffering but that don't fit the guidelines = the clinicians dilemma Summary of the POSSIBLE uses: IBD Ulcerative Colitis and Pouchitis - VSL3, E. coli nissle and saccharomyces boulardi may help for remission. No clear evidence for chron's disease IBS - VSL3, bifido infantis - mixed studies, some positive and some only as good as placebo (~50% reduction in pain) Diarrhoeal disorders (antibiotics associated, childrens diarrhoea, c.dif and preventing travellors diarrhoea) = Lacto. rhamnosus, saccharomyces boulardii and Lacto. reuteri may be of assistance e.g. reduce duration of infectious diarrhoea by Helicobacter pylori - Saccharomyces boulardii and Lacto. reuteri - may reduce side effects to antibiotics and improve eradication rate Atopic eczema - Lacto. rhamonsus and Bifido. lactis reduce rate of atopic eczema in children by 80% if taken by mother during pregnancy and breastfeeding Atopic eczema - not clear, mixed studies as a treatment of atopic eczema Other possible use though studies are limited and early - bacterial vaginosis, major depression disorder, autism spectrum disorder, other CNS disorders, hepatic encephalopathy Doses and duration's vary Risks: Do not use in critically unwell or marked immunosuppression Side effects may include - constipation, flatulence, nausea, rash and others Don't forget the price tag Some of the many references: IBD - https://www.ncbi.nlm.nih.gov/pubmed?term=20517305, https://www.ncbi.nlm.nih.gov/pubmed?term=14684584, https://www.ncbi.nlm.nih.gov/pubmed?term=22161412 IBS - https://www.ncbi.nlm.nih.gov/pubmed/25780308 Diarrhoeal disorders - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748908/ , H pylori - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588086/ Atopic disease pregnancy - https://www.racgp.org.au/your-practice/guidelines/handi/interventions/children/probiotics-in-pregnancy-for-infant-atopic-eczema/ Eczema in children - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828648/

Probiotics and intestinal permeability-- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253991/

CNS disorders = https://www.ncbi.nlm.nih.gov/pubmed/27413138